Signe Stensen

5PUBLICATIONS
17CO-AUTHORS
Metabolic medicineGene expression (incl. microarray and other genome-wide approaches)PharmacogenomicsFood properties (incl. characteristics and health benefits)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2024
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.

Laura S Hansen, Lærke S Gasbjerg, Andreas Brønden

|Jan 18, 2023
The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans.

Liva S L Krogh, Kristine Henriksen, Signe Stensen

|Jul 07, 2022
Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes.

Signe Stensen, Lærke S Gasbjerg, Mette M Rosenkilde

|May 02, 2022
Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity.

Signe Stensen, Liva L Krogh, Alexander H Sparre-Ulrich

|Apr 22, 2021
Effects of endogenous GIP in patients with type 2 diabetes.

Signe Stensen, Lærke S Gasbjerg, Liva L Krogh

Pageof 1

Frequent Collaborators

5 joint publications

Filip K Knop

4 joint publications

Lærke S Gasbjerg

4 joint publications

Bolette Hartmann

3 joint publications

Tina Vilsbøll